Massive Bio
Details
-
Anzahl der Mitarbeiter
100-500 -
Unternehmenstyp
Start-up
About Massive Bio
Massive Bio is an AI-powered precision medicine platform that transforms how cancer patients discover and access clinical trials. Founded in 2015 and headquartered in the US, the company aims to eliminate barriers such as geography and financial constraints that have historically limited patient enrollment in clinical trials. By connecting individuals to clinical trials worldwide, Massive Bio partners with leading pharmaceutical companies and healthcare systems to enhance drug development and expand access to innovative cancer treatments.
Career Opportunities
Massive Bio offers a dynamic working environment focused on professional growth and innovation in the health-tech sector. The company is recognized for its commitment to equitable access to cutting-edge therapies, providing employees with opportunities to contribute to meaningful advancements in cancer treatment.
- Collaborative and innovative work culture
- Opportunities for professional development
- Impactful work in the healthcare industry
